Abstract
No public abstract is available from the verified source records.
Harriet Rumgay, Damien Georges, Catherine de Martel, Jin Young Park, Gary M Clifford
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 186 countries
2026
Global paid and unpaid productivity losses due to cancer-related mortality
10.1093/jnci/djaf193 · 2025
Global and regional cancer burden attributable to modifiable risk factors to inform prevention
10.1038/s41591-026-04219-7 · 2026
Unresolved referenced work
2012
Carcinogenicity of hepatitis D virus, human cytomegalovirus, and Merkel cell polyomavirus
10.1016/s1470-2045(25)00403-6 · 2025
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
10.1016/s2214-109x(19)30488-7 · 2020
Global burden of cancer attributable to HIV: a worldwide incidence analysis
10.1016/s2214-109x(25)00264-5 · 2025
Estimating the global burden of Epstein–Barr virus-associated gastric cancer: a systematic review and meta-analysis
10.1016/j.cgh.2022.07.042 · 2023
Global lifetime estimates of expected and preventable gastric cancers across 185 countries
10.1038/s41591-025-03793-6 · 2025
Helicobacter pylori screen-and-treat programs for gastric cancer prevention - IARC Working Group Report
10.1056/nejmsb2515372 · 2026
Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature
10.1016/s0140-6736(24)01097-3 · 2024
Unresolved referenced work
2020
Noninferiority of one HPV vaccine dose to two doses
10.1056/nejmoa2506765 · 2025
Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study
10.1016/s0140-6736(26)00410-1 · 2026
A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale
10.1002/ijc.33185 · 2021
Recent guidelines on anal cancer screening: a systematic review
10.1097/lgt.0000000000000878 · 2025
Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus-associated oropharynx cancer early detection
10.1093/jnci/djaf249 · 2026
Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review
10.1016/s2468-1253(22)00050-4 · 2022
Unresolved referenced work
2016
Unresolved referenced work
2024
Attributable fraction of Epstein–Barr virus in subtypes of lymphoma: a systematic review and global meta-analysis
10.1002/ijc.70468 · 2026
Comprehensive molecular characterization of gastric adenocarcinoma
10.1038/nature13480 · 2014
Urgency and necessity of Epstein–Barr virus prophylactic vaccines
10.1038/s41541-022-00587-6 · 2022
Recommendations for Epstein–Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions
10.1093/jnci/djad012 · 2023
Unresolved referenced work
2025
Unresolved referenced work
2021
The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: an international assessment
10.1016/j.ejca.2018.02.003 · 2018
Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study
10.1016/s1473-3099(21)00090-6 · 2022
Cancers attributable to infections in the US in 2017: a meta-analysis
10.1001/jamaoncol.2023.4273 · 2023
Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States
10.1093/jnci/djae159 · 2024
Unresolved referenced work
2013
Statistical methods in epidemiology. III. The odds ratio as an approximation to the relative risk
10.1080/096382899297756 · 1999
The disease burden of Helicobacter pylori beyond gastric cancer: quantifying the forgotten potential benefits of mass eradication
10.1053/j.gastro.2025.08.015 · 2026
No additional external references are available.